PDF herunterladen
Planta Med 2015; 81(04): 286-291
DOI: 10.1055/s-0035-1545696
Biological and Pharmacological Activity
Original Papers
Georg Thieme Verlag KG Stuttgart · New York

Protective Effect of Tetrahydrocurcumin against Cisplatin-Induced Renal Damage: In Vitro and In Vivo Studies

Kyung Il Song   *
1   Department of Internal Medicine, University of Ulsan College of Medicine, Gangneung Asan Hospital, Gangneung, Korea
,
Jun Yeon Park   *
2   College of Korean Medicine, Gachon University, Seongnam, Korea
,
Seungyong Lee
3   Natural Products Research Institute, Korea Institute of Science and Technology, Gangneung, Korea
4   Department of Food Science, Gyeongnam National University of Science and Technology, Jinju, Korea
,
Dahae Lee
2   College of Korean Medicine, Gachon University, Seongnam, Korea
4   Department of Food Science, Gyeongnam National University of Science and Technology, Jinju, Korea
,
Hyuk-Jai Jang
5   Department of Surgery, University of Ulsan College of Medicine, Gangneung Asan Hospital, Gangneung, Korea
,
Su-Nam Kim
3   Natural Products Research Institute, Korea Institute of Science and Technology, Gangneung, Korea
,
Hyeonseok Ko
6   Laboratory of Molecular Oncology, Cheil General Hospital & Womenʼs Healthcare Center, Kwandong University College of Medicine, Seoul, Korea
,
Hyun Young Kim
4   Department of Food Science, Gyeongnam National University of Science and Technology, Jinju, Korea
,
Jae Wook Lee
3   Natural Products Research Institute, Korea Institute of Science and Technology, Gangneung, Korea
,
Gwi Seo Hwang
2   College of Korean Medicine, Gachon University, Seongnam, Korea
,
Ki Sung Kang
2   College of Korean Medicine, Gachon University, Seongnam, Korea
,
Noriko Yamabe
2   College of Korean Medicine, Gachon University, Seongnam, Korea
› Institutsangaben
Weitere Informationen

Publikationsverlauf

received 23. Juli 2014
revised 15. Januar 2015

accepted 16. Januar 2015

Publikationsdatum:
26. Februar 2015 (online)

Auch verfügbar auf
   Lizenzen und Reprints

Abstract

The adverse effects of anticancer drugs can prompt patients to end their treatment despite the efficacy. Cisplatin is a platinum-based molecule widely used to treat various forms of cancer, but frequent and long-term use of cisplatin is limited due to severe nephrotoxicity. In the present study, we investigated the protective effect and mechanism of tetrahydrocurcumin on cisplatin-induced kidney damage, oxidative stress, and inflammation to evaluate its possible use in renal damage. Cisplatin-induced LLC-PK1 renal cell damage was significantly reduced by tetrahydrocurcumin treatment. Additionally, the protective effect of tetrahydrocurcumin on cisplatin-induced oxidative renal damage was investigated in rats. Tetrahydrocurcumin was orally administered every day at a dose of 80 mg/kg body weight for ten days, and a single dose of cisplatin was administered intraperitoneally (7.5 mg/kg body weight) in 0.9 % saline on day four. The creatinine clearance levels, which were markers of renal dysfunction, in cisplatin-treated rats were recovered nearly back to normal levels after administration of tetrahydrocurcumin. Moreover, tetrahydrocurcumin exhibited protective effects against cisplatin-induced oxidative renal damage in rats by inhibiting cyclooxygenase-2 and caspase-3 activation. These results collectively provide therapeutic evidence that tetrahydrocurcumin ameliorates renal damage by regulating inflammation and apoptosis.

Key words

cisplatin - nephrotoxicity - tetrahydrocurcumin - oxidative renal damage - COX-2

* These two authors contributed equally to the work described in this study.


 

  • References

  • 1 Cai XZ, Huang WY, Qiao Y, Du SY, Chen Y, Chen D, Yu S, Che RC, Liu N, Jiang Y. Inhibitory effects of curcumin on gastric cancer cells: a proteomic study of molecular targets. Phytomedicine 2013; 20: 495-505
    CrossrefPubMedGoogle Scholar
  • 2 Wilken R, Veena MS, Wang MB, Srivatsan ES. Curcumin: a review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma. Mol Cancer 2011; 10: 12
    CrossrefPubMedGoogle Scholar
  • 3 Hurley LH. DNA and its associated processes as targets for cancer therapy. Nat Rev Cancer 2002; 2: 188-200
    CrossrefPubMedGoogle Scholar
  • 4 Miltenburg NC, Boogerd W. Chemotherapy-induced neuropathy: A comprehensive survey. Cancer Treat Rev 2014; 40: 872-882
    CrossrefPubMedGoogle Scholar
  • 5 Chorawala MR, Oza PM, Shah GB. Mechanisms of anticancer drugs resistance: an overview. Int J Pharm Sci Drug Res 2012; 4: 1-9
    PubMedGoogle Scholar
  • 6 Arany I, Safirstein RL. Cisplatin nephrotoxicity. Semin Nephrol 2003; 23: 23460-23464
    PubMedGoogle Scholar
  • 7 Zhu M, Chen J, Yin H, Jiang H, Wen M, Miao C. Propofol protects human umbilical vein endothelial cells from cisplatin-induced injury. Vascul Pharmacol 2014; 61: 72-79
    CrossrefPubMedGoogle Scholar
  • 8 Kohn S, Fradis M, Ben-David J, Zidan J, Robinson E. Nephrotoxicity of combined treatment with cisplatin and gentamicin in the guinea pig: glomerular injury findings. Ultrastruct Pathol 2002; 26: 371-382
    CrossrefPubMedGoogle Scholar
  • 9 Li Q, Tian Y, Li D, Sun J, Shi D, Lin F, Gao Y, Liu H. The effect of lipocisplatin on cisplatin efficacy and nephrotoxicity in malignant breast cancer treatment. Biomaterials 2014; 35: 6462-6472
    CrossrefPubMedGoogle Scholar
  • 10 Luke DR, Vadiei K, Lopez-Berestein G. Role of vascular congestion in cisplatin induced acute renal failure in the rat. Nephrol Dial Transplant 1992; 7: 1-7
    PubMedGoogle Scholar
  • 11 Miller RP, Tadagavadi RK, Ramesh G, Reeves WB. Mechanisms of Cisplatin nephrotoxicity. Toxins (Basel) 2010; 2: 2490-2518
    CrossrefPubMedGoogle Scholar
  • 12 Kang KS, Ham J, Kim YJ, Park JH, Cho EJ, Yamabe N. Heat-processed Panax ginseng and diabetic renal damage: active components and action mechanism. J Ginseng Res 2013; 37: 379-388
    CrossrefPubMedGoogle Scholar
  • 13 Kim JH, Han IH, Yamabe N, Kim YJ, Lee W, Eom DW, Choi P, Cheon GJ, Jang HJ, Kim SN, Ham J, Kang KS. Renoprotective effects of Maillard reaction products generated during heat treatment of ginsenoside Re with leucine. Food Chem 2014; 15: 114-121
    PubMedGoogle Scholar
  • 14 Lee JH, Lee W, Lee S, Jung Y, Park SH, Choi P, Kim SN, Ham J, Kang KS. Important role of Maillard reaction in the protective effect of heat-processed ginsenoside Re-serine mixture against cisplatin-induced nephrotoxicity in LLC-PK1 cells. Bioorg Med Chem Lett 2012; 22: 5475-5479
    CrossrefPubMedGoogle Scholar
  • 15 Nath KA, Norby SM. Reactive oxygen species and acute renal failure. Am J Med 2000; 109: 665-678
    CrossrefPubMedGoogle Scholar
  • 16 Taguchi T, Nazneen A, Abid MR, Razzaque MS. Cisplatin-associated nephrotoxicity and pathological events. Contrib Nephrol 2005; 148: 107-121
    PubMedGoogle Scholar
  • 17 Jiang M, Dong Z. Regulation and pathological role of p 53 in cisplatin nephrotoxicity. Pharmacology 2008; 327: 300-307
    PubMedGoogle Scholar
  • 18 Pabla N, Dong Z. Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. Kidney Int 2008; 73: 994-1007
    CrossrefPubMedGoogle Scholar
  • 19 Yamabe N, Song KI, Lee W, Han IH, Lee JH, Ham J, Kim SN, Park JH, Kang KS. Chemical and free radical-scavenging activity changes of ginsenoside Re by Maillard reaction and its possible use as a renoprotective agent. J Ginseng Res 2012; 36: 256-262
    CrossrefPubMedGoogle Scholar
  • 20 Yamabe N, Kim YJ, Lee SY, Cho EJ, Park SH, Ham JY, Kim HY, Kang KS. Increase in antioxidant and anticancer effects of ginsenoside Re-lysine mixture by Maillard reaction. Food Chem 2013; 138: 876-883
    CrossrefPubMedGoogle Scholar
  • 21 Huang MT, Lysz T, Ferraro T, Abidi TF, Laskin JD, Conney AH. Inhibitory effects of curcumin on in vitro lipoxygenase and cyclooxygenase activities in mouse epidermis. Cancer Res 1991; 51: 813-819
    PubMedGoogle Scholar
  • 22 Huang MT, Ma W, Yen P, Xie JG, Han J, Frenkel K, Grunberger D, Conney AH. Inhibitory effects of topical application of low doses of curcumin on 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion and oxidized DNA bases in mouse epidermis. Carcinogenesis 1997; 18: 83-88
    CrossrefPubMedGoogle Scholar
  • 23 Sandur SK, Ichikawa H, Pandey MK, Kunnumakkara AB, Sung B, Sethi G, Aggarwal BB. Role of pro-oxidants and antioxidants in the anti-inflammatory and apoptotic effects of curcumin (diferuloylmethane). Free Radic Biol Med 2007; 43: 568-580
    CrossrefPubMedGoogle Scholar
  • 24 Yoysungnoen P, Wirachwong P, Changtam C, Suksamrarn A, Patumraj S. Anti-cancer and anti-angiogenic effects of curcumin and tetrahydrocurcumin on implanted hepatocellular carcinoma in nude mice. World J Gastroenterol 2008; 7: 2003-2009
    PubMedGoogle Scholar
  • 25 Murugan P, Pari L. Effect of tetrahydrocurcumin on lipid peroxidation and lipids in streptozotocin-nicotinamide-induced diabetic rats. Basic Clin Pharmacol Toxicol 2006; 99: 122-127
    CrossrefPubMedGoogle Scholar
  • 26 Yokozawa T, Cho EJ, Hara Y, Kitani K. Antioxidative activity of green tea treated with radical initiator 2, 2′-azobis (2-amidinopropane) dihydrochloride. J Agric Food Chem 2000; 48: 5068-5073
    CrossrefPubMedGoogle Scholar
  • 27 Forbes JM, Coughlan MT, Cooper ME. Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes 2008; 57: 1446-1454
    CrossrefPubMedGoogle Scholar
  • 28 Heyman SN, Rosen S, Rosenberger C. A role for oxidative stress. Contrib Nephrol 2011; 174: 138-148
    PubMedGoogle Scholar
  • 29 Li JM, Shah AM. ROS generation by nonphagocytic NADPH oxidase: potential relevance in diabetic nephropathy. J Am Soc Nephrol 2003; 14: 221-226
    CrossrefPubMedGoogle Scholar
  • 30 Takeda H, Sadakane C, Hattori T, Katsurada T, Ohkawara T, Nagai K, Asaka M. Rikkunshito, an herbal medicine, suppresses cisplatin-induced anorexia in rats via 5-HT2 receptor antagonism. Gastroenterology 2008; 134: 2004-2013
    CrossrefPubMedGoogle Scholar
  • 31 Jonker JW, Schinkel AH. Pharmacological and physiological functions of the polyspecific organic cation transporters: OCT1, 2, and 3 (SLC22A1–3). J Pharmacol Exp Ther 2004; 308: 2-9
    PubMedGoogle Scholar
  • 32 Harris RC. Cyclooxygenase-2 in the kidney. J Cardiovasc Pharmacol 2006; 47: 37-42
    CrossrefPubMedGoogle Scholar
  • 33 Kim GH. Renal effects of prostaglandins and cyclooxygenase-2 inhibitors. Electrolyte Blood Press 2008; 6: 35-41
    CrossrefPubMedGoogle Scholar
  • 34 Cohen GM. Caspases: the executioners of apoptosis. Biochem 1997; 326: 1-16
    CrossrefPubMedGoogle Scholar
  • 35 Yang B, Johnson TS, Thomas GL, Watson PF, Wagner B, Nahas AM. Apoptosis and caspase-3 in experimental anti-glomerular basement membrane nephritis. J Am Soc Nephrol 2001; 12: 485-495
    PubMedGoogle Scholar
  • 36 Mukhopadhyay P, Rajesh M, Pan H, Patel V, Mukhopadhyay B, Bátkai S, Gao B, Haskó G, Pacher P. Cannabinoid-2 receptor limits inflammation, oxidative/nitrosative stress, and cell death in nephropathy. Free Radic Biol Med 2010; 48: 457-467
    CrossrefPubMedGoogle Scholar